Vera Therapeutics, Inc. — Director's Dealing 2021

Jul 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vera Therapeutics, Inc. (VERA)
CIK: 0001831828
Period of Report: 2021-07-13

Reporting Person: Grant Sean (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-13	Stock Option (right to buy)	$14.87	A	180000	Acquired	2031-07-12	Class A Common Stock (180000)	Direct

Footnotes

F1: 1/4 of the shares subject to the option vest on July 12, 2022, and 1/48 of the shares vest monthly thereafter.